Viewing Study NCT05879458


Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2026-02-22 @ 7:22 PM
Study NCT ID: NCT05879458
Status: TERMINATED
Last Update Posted: 2025-07-18
First Post: 2023-05-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ritlecitinib in CTCL
Sponsor: Icahn School of Medicine at Mount Sinai
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module